14 August 2014 | Neurogenin 3 is important but not essential for pancreatic islet development in humans. | Rubio-Cabezas, O; Codner, E; Flanagan, SE; et al. |
5 April 2016 | Type 1 Diabetes Genetic Risk Score: a novel tool to discriminate monogenic and type 1 diabetes | Patel, KA; Oram, RA; Flanagan, SE; et al. |
17 September 2018 | ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents | Hattersley, AT; Greeley, SAW; Polak, M; et al. |
3 October 2018 | Homozygosity mapping provides supporting evidence of pathogenicity in recessive Mendelian disease | Wakeling, MN; Laver, TW; Wright, CF; et al. |
4 June 2018 | Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study | Bowman, P; Sulen, Å; Barbetti, F; et al. |
8 April 2019 | Trisomy 21 is a Cause of Permanent Neonatal Diabetes that is Autoimmune but not HLA Associated | Johnson, MBJ; De Franco, E; Atma W Greeley, S; et al. |
5 July 2019 | Type 1 diabetes genetic risk score discriminates between monogenic and Type 1 diabetes in children diagnosed at the age of < 5 years in the Iranian population | Yaghootkar, H; Abbasi, F; Ghaemi, N; et al. |
3 May 2017 | Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts | De Franco, E; Flanagan, SE; Yagi, T; et al. |
27 December 2019 | De novo mutations in EIF2B1 affecting eIF2 signaling cause neonatal/early onset diabetes and transient hepatic dysfunction | De Franco, E; Caswell, R; Johnson, M; et al. |
4 June 2018 | Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study | Bowman, P; Sulen, Å; Barbetti, F; et al. |